Why are eligible patients not prescribed aspirin in primary care? A qualitative study indicating measures for improvement.
BACKGROUND
Despite evidence-based guidelines, aspirin prescribing for the secondary prevention of stroke is sub-optimal. Little is known about why general practitioners do not prescribe aspirin to indicated patients. We sought to identify and describe factors that lead general practitioners (GPs) not to prescribe aspirin to eligible stroke patients. This was the first stage of a study exploring the need for and means of improving levels of appropriate aspirin prescribing.


METHODS
Qualitative interviews with 15 GPs in the West Midlands.


RESULTS
Initially, many GPs did not regard their prescribing as difficult or sub-optimal. However on reflection, they gave several reasons that lead to them not prescribing aspirin for eligible patients or being uncertain. These include: difficulties in applying generic guidelines to individuals presenting in consultations, patient resistance to taking aspirin, the prioritisation of other issues in a time constrained consultation and problems in reviewing the medication of existing stroke patients.


CONCLUSIONS
In order to improve levels of appropriate aspirin prescribing, the nature and presentation risk information available to GPs and patients must be improved. GPs need support in assessing the risks and benefits of prescribing for patients with combinations of complicating risk factors, while means of facilitating improved GP-patient dialogue are required to help address patient uncertainty. A decision analysis based support system is one option. Decision analysis could synthesise current evidence and identify risk data for a range of patient profiles commonly presenting in primary care. These data could then be incorporated into a user-friendly computerised decision support system to help facilitate improved GP-patient communication. Measures of optimum prescribing based upon aggregated prescribing data must be interpreted with caution. It is not possible to assess whether low levels of prescribing reflect appropriate or inappropriate use of aspirin in specific patients where concordance between the GP and the patient is practised.
Short
Duncan
D
Department of Medicines Management, University of Keele, Keele, Staffordshire, UK, ST5 5BG. d.short@keele.ac.uk
Frischer
Martin
M
Bashford
James
J
Ashcroft
Darren
D
D001241:Aspirin / Q000627:therapeutic use*; D001291:Attitude of Health Personnel; D011307:Drug Prescriptions; D006801:Humans; D010349:Patient Compliance; D010821:Physicians, Family; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D010818:Practice Patterns, Physicians'; D012008:Recurrence; D020521:Stroke / Q000209:etiology / Q000517:prevention & control*; D016312:Treatment Refusal
D010975:Platelet Aggregation Inhibitors; D001241:Aspirin